PVLA
Palvella Therapeutics
PVLA
PVLA
65 hedge funds and large institutions have $40.1M invested in Palvella Therapeutics in 2022 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 13 increasing their positions, 21 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
38% less repeat investments, than reductions
Existing positions increased: 13 | Existing positions reduced: 21
41% less capital invested
Capital invested by funds: $68.3M → $40.1M (-$28.2M)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Holders
65
Holding in Top 10
1
Calls
$126K
Puts
$18K
Top Buyers
| 1 | +$345K | |
| 2 | +$335K | |
| 3 | +$275K | |
| 4 |
Renaissance Technologies
New York
|
+$174K |
| 5 |
PIM
Platinum Investment Management
Sydney Australia 2000,
Australia
|
+$140K |
Top Sellers
| 1 | -$1.34M | |
| 2 | -$629K | |
| 3 | -$396K | |
| 4 |
XT
XTX Topco
George Town,
Cayman Islands
|
-$186K |
| 5 |
Man Group
London,
United Kingdom
|
-$160K |